Getting to 90–90–90: Experiences from the MaxART Early Access to ART for All (EAAA) Trial in Eswatini
Sign Up to like & getrecommendations! Published in 2020 at "Current HIV/AIDS Reports"
DOI: 10.1007/s11904-020-00501-6
Abstract: Purpose of Review The MaxART Consortium—led by the Eswatini Ministry of Health—implemented multiple interventions between 2012 and 2017 to achieve UNAIDS 90–90–90 targets. We summarize key findings from community outreach strategies in support of the… read more here.
Keywords: eaaa trial; trial; hiv; early access ... See more keywords
Voting Rights and Immigrant Incorporation: Evidence from Norway
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Political Science"
DOI: 10.1017/s0007123417000643
Abstract: How do political rights influence immigrant integration? This study demonstrates that the timing of voting rights extension plays a key role in fostering political incorporation. In Norway, non-citizens are eligible to vote in local elections… read more here.
Keywords: early access; voting rights; immigrant incorporation; evidence ... See more keywords
OP173 Eligibility Criteria For “Accelerated Access” Approval: A Global Survey
Sign Up to like & getrecommendations! Published in 2018 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462318001757
Abstract: Introduction: Several early access schemes (EAS) exist, which aim to accelerate patient access to new, potentially life-saving therapies. While some information exists on key schemes and their modalities, the determinants that drive adoption of a… read more here.
Keywords: eligibility criteria; early access; survey; percent ... See more keywords
PP81 Real World Data: The Early Access To Medicines Scheme Catches The Worm
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462319002241
Abstract: Introduction The Early Access to Medicines Scheme (EAMS) aims to provide access to medicines prior to market authorization for patients with severe, life-threatening diseases who do not have adequate treatment options. An EAMS designation enables… read more here.
Keywords: access medicines; access; real world; early access ... See more keywords
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy.
Sign Up to like & getrecommendations! Published in 2022 at "European journal of neurology"
DOI: 10.1111/ene.15325
Abstract: BACKGROUND Hereditary transthyretin amyloidosis (ATTRv) is a dominantly inherited, adult-onset, progressive and fatal disease caused by mutations in the transthyretin gene. Therapeutic agents approved for this disease include the TTR stabilizer tafamidis and the gene-silencing… read more here.
Keywords: early access; access program; program; hereditary transthyretin ... See more keywords
Early access provision: Awareness, educational needs and opportunities to improve oncology patients’ access to care
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.714516
Abstract: Background An unmet medical need exists for many oncology patients who cannot be treated satisfactorily by available therapeutic options. Early access provision (EAP) is endorsed by competent authorities to improve patient access to innovative medicinal… read more here.
Keywords: early access; oncology; oncology patients; access provision ... See more keywords
Early Access to Oral Antivirals in High-Risk Outpatients: Good Weapons to Fight COVID-19
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14112514
Abstract: Introduction: Molnupiravir and Nirmatrelvir/r (NMV-r) have been proven to reduce severe Coronavirus Disease 2019 (COVID-19) in unvaccinated high-risk individuals. Data regarding their impact in fully vaccinated vulnerable subjects with mild-to-moderate COVID-19 are still limited, particularly… read more here.
Keywords: early access; composite outcome; high risk; risk outpatients ... See more keywords